ATLASX4 Pharmaceuticals (XFOR) earnings date: Nov 4, 2026
X4 Pharmaceuticals (XFOR) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of -$0.19.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on XFOR
| Last price | $3.35 (-0.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the X4 Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
X4 Pharmaceuticals reports on Nov 4, 2026. One email the day before, with ATLAS’s read on X4 Pharmaceuticals. You can switch it off at any time.
Alert me before XFOR reportsFree to start. Creating an account takes under a minute.
XFOR earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.19 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +32.4% |
| Average move around a report | ±7.7% (last 5) |
| Sector | Healthcare · Biotechnology |
X4 Pharmaceuticals earnings history: last 5 reports
X4 Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.13 against an estimate of -$0.18 (+27.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.18 | -$0.13 | +27.8% | Beat | +11.8% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | +7.2% |
| May 6, 2026 | -$0.20 | -$0.16 | +20.0% | Beat | +2.1% |
| Mar 17, 2026 | -$0.35 | -$0.22 | +37.1% | Beat | +13.8% |
| Feb 10, 2026 | $0.96 | $1.00 | +4.2% | Beat | -3.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for XFOR
See the fair value, the probability range and the earnings history of X4 Pharmaceuticals on its ATLAS page.
X4 Pharmaceuticals (XFOR) stock analysisPlans from €3.99 a month.
X4 Pharmaceuticals earnings: frequently asked questions
When does X4 Pharmaceuticals (XFOR) report earnings?
X4 Pharmaceuticals is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for XFOR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.19 per share (USD). Estimates can change before the report.
How often does XFOR beat earnings estimates?
Of its last 5 reports with a recorded result, X4 Pharmaceuticals beat the EPS estimate 5 times; the average surprise was +32.4%. Past results do not predict the next one.
How much does XFOR move around earnings?
Over its last 5 reports the stock moved an average of 7.7% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did X4 Pharmaceuticals beat earnings estimates last quarter?
X4 Pharmaceuticals last reported on Aug 6, 2026: EPS of -$0.13 against an estimate of -$0.18 (+27.8% surprise), a beat.
How much does XFOR usually move in a day?
On a normal trading day the ATLAS model puts XFOR’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer